Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
And when we pull the labs and look at free T3, which should be above three
B12 shots are intramuscular injections containing vitamin B12, essential for red blood cell formation, neurological function, and DNA synthesis
This is often when IGF-1 LR3 cycles show their peak effects
Given that vagal afferents innervate the ENS, it is plausible that the ENS can relay local intestinal signaling mechanisms to the CNS
Common side effects of semaglutide can include nausea, vomiting, diarrhea and stomach pain
